While one AGS patient with biallelic SAMHD1 GVs and chronic lymphocytic leukemia has been described [17], heterozygous GVs in SAMHD1 have been detected in a multiple myeloma family and significantly associated with prostate cancer risk [13, 52]. This evidence concerns the gene SAMHD1 and plasma cell myeloma.